The clinical efficacy of rcrinoids in benign and malignant skin diseases involving immune mechanisms suggests that they affect the im munologic functions of the epidermis. H owever. these e.ffects have yet co be demonstrated. The action of vitamin A (retin ol) and the synthetic rerinoids, isorretinoin. crrcrinarc, ac.irrerLn, and arotinoid-free acid have been studied on rhe lymphocyte proliferation induced by phytohemagglutinin (PHA), by the mixed lymphocyte reaction (MLR), and rhe mixed epidermal cell-lymphocyte reaction (MECLR). The results for PHA-induced.rroliferations were highly variable for all the retinoids. However, in MEC LR, the synthetic rctinoids consistently reduced the proliferation by 20% -30%. This occurred at therapeutic drug concentrations of about 10-7M. In MLR, a minor decrease af 10% -15 % was only found far higher cancentra-V itamin A derivatives (i.e .. retinoids) have beneficial effects not only 011 skin diseases with abnormal epidermal proliferation and differentiation such as psoriasis or ich th yosis, but aJso on diseases involving abnormal interactions between lymphocytes and epidermis (e.g., lichen pLanus or cutaneous T -cell lymphoma) [1 .2].
[ions (10-S M) . Retinol induced no effect in either reaction. Further analysis of acitretin on MECLR showed that it reduced lymphocyte proliferation in a dose-dependent fashion. This reduction was combined with a decrease in cytotOxic T-Iymphocyte induction (CTL). Addition oflO--M acitretin at various times also revealed that its presence at cell culture initiation was necessary to inhibit proliferation signi£cantl y. Furthermore, cell trea tments prior to MECLR showed that exposure of epidermal cells to acitretin was essential to produce this inhibition, suggesting that it acts directly on cpidennal cells. Consequently, it is suggested that the specific inhibitory effect of synthetic tetinoids on lymphocyteactivation in MECLR may partly account for their therapeutic action on the skin. J Irlllest Dermatol 93:455 -459, 1989 sensitivity 1.5] . skin allograft rej ection [6] . and antitumoral immunity in mice [7] . H owever, delayed-type hypersensitivity reaction also can be inh ibited if reti noids are given during the sensitization phase [8] . Contradictory data have been reported concerning macrophage, [9] .
The immunologic properties of the skin are now well documented. Epidermal Langerhans cell s are dendritic bone marrow-deri ved ceUs that sy nth esize and ex press class II histocompatibility antigens (e.g., HLA-DR) 110). They are effective antigen-presentin g cells in allogeneic and antigen specific proliferation and in cytotoxic T-cell responses. Like macrophages. they produce inter leukin-l (IL-l ). Keratinocytes aJso secrete soluble factors that may enhance or inhibit T -cell proliferation and differentiation, including IL-I [II] . th ymopO"ietin [12] . and prostaglandins [13] . On the other hand , lymphocytes may also affecr the epidermis. For instance, the Iymphokine interferon-/' induces HLA-DR expression by kerati nocytes [14] . In short , although epidermal ceUs and lymphocytes are known to influence each or her's proliferation and differentiation via cellulat and soluble factors, nothing is known about the modulation of these factors by the rerinoids . The mixed epidermal ce ll-l ymphocyte reaction (MECLR) is a well-defined reaction in which epidermal cells strongly stimulate proliferation of allogem'ic lymphocytes. This reaction was recently shown to be a reliable predictive model in graft-versus-host disease. which involves epidermal cell-lymphocyte interactions 115J. Tberefore, MECLR appears to be a useful tool for studying pharmacologic modulation in cutaneous immune reactions.
1n rhe present work, we investigated the action of rerinoids on the immunologic functions of the epidermis. For this purpose. we studied the effects of retinol and synthetic analogues upon the MECLR in humans. We demonstrated that vitamin A derivatives specifically inhibit the lymphocyte activation by allogeneic epidermal cells. Furthermore, the observation that the inhibition of the MECLR by 0022-202X/89/S03.50 Copyright © 1989 by The Society for Investigative Dermatology. Inc.
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rcrinoids requires either early addition of th e drugs eo rhe cultures or pretreatment of the epidermal cells. suggests that rerinoids act direcdy o n the antigen presenting properties of these cells.
MATERIALS AND METHODS
Materials Sixteen healthy adult volunteers (ten men and six women) were recruited with rhe agreement of the hospital ethics committee. Their ages ranged from 18 to 39 years, with a mean age of26.
Peripheral blood mononucl ear cells (PBMC) were isolated from heparinized venous blood samples by centrifugation over Ficoll Hypaque densiry gradients (Eurobio, Paris, France). Epiderma l shee rs were obtained from suction blister roofs on thigh skin. Each blister was removed with scissors and washed in McKeehan's sol ution (Flow Laboratories. Irvine. United Kin gdom). The sheers were em ineo small pieces, incubated in a 0.3% solucion of trypsin for 15 min , and again washed in McKeehan's solution. The resulting dispersed cells were centrifuged and resuspended in culture medium. Using these procedures, we obtained more than 80% of viable epidermal cel ls.
Medium consisted of RPMI 1640 (Flow Laboratories, Irvine, Un..ired Kingdom) supple mented with L-giutamine (1 %). nonessen tial amino acids (1 %), penicillin-streptomycin (1 %). HEPES buffer (3%). and decomplemented human AB se rum (10%). Mole:cules studied were the natural rerinoid re.tinol (Ro 01-5488) and four synthetic retinoids: isotretinoin (Ro 04-3780), etrerinate (Ro 10-9359), acitretin (Ro 10-1670), and arotinoid-free acid (Ro 13-7410). These re.rinoids were initially srored in 10% dimethylsulfoxide (DMSO) at -20°C. Because retinoids afe light-sensitive, they were diluted in th e medium JUSt before addition to the wells. and cul tures were incubated in the dark. Cultures containing similar amounts of DMSO only were used as con trol s. (~ICr release by responder cells -spontaneous Ster release) X 100 Total amount oPICr incorporation into rarget cells -spomaneous ~ICr release Statistical Analysis Results were analyzed for sta tistical signi.ficance using the rwo way-analysis of variance, and the Student's I-test.
RESULTS
Direct Cytotoxiciry of the Retinoids and Their Solvants A direcr cytotoxic eftect appeared after a 4-h incubation. After 18 h, 1 % DMSO or ethanol significantly reduced rhe viabiliry of both lymphocytes and epidermal cells (p<0.02) . A more toxic effect was observed with 1O-4 M retinol , acitrerin or arotinoid-free acid in th e presence of 1 % DMSO (p<O.O I ) } whereas isotrerinoin and erretinate at the sa me concemrations did nor produce any effect in addi ti on to that ofDMSO. For up to overnight (-16 h). cell viabiliry in rhl": presence of both 10-s M retinoid and 0.1 % DMSO was about 60% of the in.itial concentration, i.e., similar to that observed in control medium. except for lO-~M rctinol. which was srill slightly {Oxic on lymphocytes (p = 0.08). With 10-6 rerinol. no decrease of lymphocyte viability was observed. Additional experime.nts using the MIT assays showed again thar IO-SM acirrctin induced no reduction on lymphocyte and epidermal cell viability, compared with the controis (medium, and 0.1 % DMSO) (data not shown).
Synthetic Retinoids Significantly Decreased tbe Lymphocyte P rolifer ation in MECLR Four indt'pcndt'nt exper.iments on the Iymphocyre proliferation induced by PHA. MLR, and MECLR were co nducted for each retinoid. Figure 1 illustrates the compa rative results with lO-6M acitrctill.
At concentrations between lO-ftM and to-SM. etretinate and acirretin tended to inhibit PHA-induced proliferation. The other retinoids often exhibited no effect. However, none of these results was consistentlyobserved.
In MLR, isorretinoin, acitrctin and arotinoid-free ac.id onlv inhibited lymphocyte proliferation slightly by 10%-15%. Moreover, this inhibition only occurred at rhc. high c.nncenrr~rion or 10-s M .
Neither retinol nor ('ereeinate had any inhibitory or stimulamry effect.
In MECLR, the inhibition oflymphocytc proliferation by all the rerinoids except retinol was consiste ntl y higher rhan that observed ill MLR. Ardrug concentrations berween 10-S M and 1 0-1M, isotrctinoin, acirrecin, and arotinoid-frce acid reduced [JH]thym.idinc incorporation into lymphocy tes. by 20%-30%. In some acitretinrreated cultures. addition of 5 . 10 1 M indomethacin (ClRD, Sophia-Antipolis, France). which is known as an inhibitor of prostaglandin synth esis, did not lead to a reduction of this inhibition. Etretinate induced less inhibition than the other sy nrheti c rerinoids (10% -20%). At retinoid concentrations of 10--9M, there was no difference between proliferation in the retinoid groups and the DMSO comrol groups.
A twO way-analysis of variance was realized on the results obtained with 10--6M retinol and acitrctin, in MLR and MECLR MLR . and MEC LH cultures exposed to 0.01% OMSO (=100). Error him represent mcam. ± SO of the total values in each reacoon.
( 
Dose.Respon se C u rves W ith Acitretin in MLR a nd MEC LR
T o esrablish dose-response curves, lymphocyte proliferation in MLR and MECLR was studied in the presence of various concentrations of acitretin. The final concentration of DMSO in each well was 0.0 I %. T he results of rwo separa re experim ents confirmed those of the described studies, because inhibition of cell proliferati on was significantl y higher in MECLR than in MLR (Fig 2) . In MECLR. rhe decreast:" in IlH Jthymidine uprake by th e lymphocytes was clearly dose dependcnr. and reached a plateau of inhibition at about 30% for an approxirnare aCltretin concentration of 1 a-1 M.
Acitretio Inhi bits the C11.. lnduct ion in ME CLR In rwo separate experiments, rhe induction of a cyrotoxic lymphocyte (CTL) acrivity in rhe presence of 10--6 and IO-II M acitrerin was tested in MECLR. In this reaction, 10-6 M acitrerin signilicanr\y reduced not only rhe proliferation bur also CTL activity (Fi g 3), whereas no Effector to target cell ratio after day 0, either once on day 1,2,3, or 4, or rwice on days 1 and 3. did nor induce any difference in proliferation versus the control group.
In th e second set of experiments. responder lymphocytes and srim ui acof epidermal cells were preincubared before MECLR with 10' M acitrerin or 0.01% DMSO, as described in Methods. The results of three independent experiments with overnight pfeineu. baricn (Table II) showed 1) the decrease in lymphocyte p.roliferarion could be reproduced by treating born responder and stimulator cells wi th aeletetin ; 2) preincubation of responder cdls alone with acittetin did not induce any significant effect; and 3) preincubation of stimulator epidermal cells only with aci trecin significantly reduced [3HJthymidine incorporation by responder lymphocytes.
When the pteincubation period was 2 h. no significant effect was found, whatever the treatment.
DISCUSSION
We have dcmonstratcd that in human MECLR. nontoxic concentrations of four synthetic rerinoids significantly inhibited lymphocyte proliferation, w hereas the natural product' retinol had no effect. Inhibi tion of lymphocyte proliferation was combined with a decrease of C TL activity induction. It occurred at an early stage in cell culture and mainly affected 5timulator epidermal cells.
Laboratory experiments have confirmed thar retinoids act on most componen ts of the immune system, including T lymphocytes [9] . Retinoids regulate either up or down T -eel! functions, depending on the experimental conditions. Thus, proliferation of human T cells induced by PHA was i_ nhibited in vitro by retinol [18] . isotre- [3] and isocrctinoin in vivo 121]. Similarly, in the MLR. retinoic acid reduced bov ine lymphocyte proliferation [221 bue, in vivo, rctin yl ester prevented the suppression of the MLR nonnally found in patients after surgery {23]. Data. concerning the effects of retinoids on human MLR are not presently available, In bric{ rctinoids seem ro display bifunctional activiry that makes their usual beneficial effects 011 cuta.neous immune reactions difficult to explain. Dosage problems may account for these discrepant results . Our kinetic study of cell viabiliry using trypan blue exclusion clearly showed t har rerinoids and their solvants (DMSO and ethanol) werC' direcdy cytotoxic at concentrations above 1O-!iM and 0. 1 %, respectively. This toxicity probabl y partially explains the inhibitory in vitro effecr of rctinoids on lymphocyte proliferation reported by some authors [18-20. 22, 24J. On the oth er hand, we confirmed that the effects of retinoids on PH A-induced proliferations are variable, Noncytotoxic co ncentrations of etretinate and more especially, acitrerin, had rather inhibitory effects as recently reported by Shetbany and co-workers [4J. to 1 Q-'M. Irs action on epidermal cells was crucial fo r inducing th_ is inhibition. As we did nOf perform modulation stud.ies using purified or Langerhans cell-enriched epidermal cell cultures, the mechanism of action by which synthetic rerinoids act on epidermal cells remains to be dete rmined. It is known that an inc.reased expression of la antigens on mouse Langerhans cell is associated with an enhanced capac ity of antigen presentation by rhest" cells [26] . Some th eir HLA-DR antigen production. It mi gh t also act through the accessory functions of epidermal cell s, by modulating the production of the cytok.ines quoted above. The retinoid effects on prostaglandin -E:;! seem unlikely because here th e prostaglandin inhibitor, indomcthaci n, had no action on the aeitretin inhibition. Alternatively, rctinoids mi gh t also act directl y on epidermal cell membranes.
It is noteworthy that, in our da ta. rcti noids with a free carboxyl group in th e CIS position significantl y inhibited th e MEC LR, whereas retinol and enctinate, which respectively have an alcohol and a dimethylethylesrer function in this position, induced a weaker or nonsignificant action. Because the availabiliry of this free carboxyl function is a necessary condition for binding to the cell ular retinoi c acid binding protein (C RABP) [33] , this latter mi ght mediate the effects of active rctinoids on epidermal cells during MECLR. T hus, the predominance of C RABP in epidermal cel ls may explain in pan the specific action of rhe synth eric rcrinoids in MECLR [34] .
We observed that the synth etic analogues of vita min A had a spec ific action in MEC LR, whereas retinol did not. New active derivatives such as aci tretin. the main metabolite of etrctinace, and arotinoid-free-acid induced a greater inhibition [han already commerc ialized rcrinoids-such as isotretinoin and errecmate. MECLR mi ght therefore be a useful cool for assessing the in vitro immunologic action of new molecules. Howeve r. it remains to be established that th e down-mod ul ation by rctinoids of lymphocyte activa tion, and the magnitu de of th is regulation in vitro refleer the situation in vivo. The changes caused by retinoids in th e-interaction between epidermal cel ls and lymphocytes may partly explain their the rape utic effects on the skin.
